Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-22-000042
Filing Date
2022-01-05
Accepted
2022-01-05 12:38:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 d9128048_13-g.htm SC 13G 123447
  Complete submission text file 0000919574-22-000042.txt   124958
Mailing Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540
Business Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540 609-419-1800
CAXTON CORP (Filed by) CIK: 0001388551 (see all company filings)

EIN.: 222437619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 844-445-5704
Xeris Biopharma Holdings, Inc. (Subject) CIK: 0001867096 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93215 | Film No.: 22510238
SIC: 2834 Pharmaceutical Preparations